Matches in Nanopublications for { ?s ?p "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_provenance.
- NP651505.RAy89Bw2ElEicLWB3EEZZ8nacS5HifNe4gxx_QgDlRSTQ130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651505.RAy89Bw2ElEicLWB3EEZZ8nacS5HifNe4gxx_QgDlRSTQ130_provenance.
- NP524863.RAvuJvXNthdCtMDV7jZJfuvxruyHF9b3WEIXAxmIgVMr0130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524863.RAvuJvXNthdCtMDV7jZJfuvxruyHF9b3WEIXAxmIgVMr0130_provenance.
- NP422917.RAIaOGnLhOX9-pjgXv6yTzu8wG59WsVfk7lFWXkBu9sVk130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422917.RAIaOGnLhOX9-pjgXv6yTzu8wG59WsVfk7lFWXkBu9sVk130_provenance.
- NP524311.RA5U_mVXHaKTciCTsjHWY8hhxIxtTVoFMvRMNWK9nM5To130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524311.RA5U_mVXHaKTciCTsjHWY8hhxIxtTVoFMvRMNWK9nM5To130_provenance.
- NP660651.RAOZzNTEBq4FHxe7gvwrNevjNnmRCoGFP26dbnRQ18QDo130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660651.RAOZzNTEBq4FHxe7gvwrNevjNnmRCoGFP26dbnRQ18QDo130_provenance.
- NP660654.RAEyqS4SXBHJ7m_Bt2dp41MWGS7Aq3LQ1HDFr463jGzyo130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660654.RAEyqS4SXBHJ7m_Bt2dp41MWGS7Aq3LQ1HDFr463jGzyo130_provenance.
- NP660657.RAws_7vtkk47GfktrpC8OjmXGNfxYTLjnqn4KqMeORn3k130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660657.RAws_7vtkk47GfktrpC8OjmXGNfxYTLjnqn4KqMeORn3k130_provenance.